WaveMan · Form 4
Chacko Jacob insider trades
> Search tickers & screens ⌘K
LIVE

Chacko Jacob insider trades

Chacko Jacob has filed 30 Form 4s with the SEC that we hold, for Oric Pharmaceuticals, Inc. (ORIC) (PRESIDENT AND CEO, Director) and 4D Molecular Therapeutics, Inc. (FDMT) (Director). Across all of them we count 6 purchases worth $3.0M and 23 sales worth $5.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($302.4K). The largest single trade was a sale of 125,000 shares of Oric Pharmaceuticals, Inc. worth $1.4M, dated 2025-09-22. The first filing on our record is dated 2021-09-09 and the latest 2026-06-18.

Oric Pharmaceuticals, Inc. (ORIC)

PRESIDENT AND CEO, Director · 24 filings · 28 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-07S, sale reported on Form 45,981$150.2K2021-09-09
2021-09-08S, sale reported on Form 4200$5.0K2021-09-09
2021-09-10S, sale reported on Form 42,942$73.8K2021-09-14
2021-09-13S, sale reported on Form 42,801$70.1K2021-09-14
2021-09-14S, sale reported on Form 44,420$110.7K2021-09-16
2021-09-15S, sale reported on Form 43,736$93.6K2021-09-16
2022-03-23P, purchase reported on Form 4257,127$1.3M2022-03-25
2022-03-24P, purchase reported on Form 442,873$215.7K2022-03-25
2022-03-25P, purchase reported on Form 450,000$227.0K2022-03-25
2022-05-11P, purchase reported on Form 4304,574$883.3K2022-05-13
2022-05-12P, purchase reported on Form 469,354$190.7K2022-05-13
2022-05-13P, purchase reported on Form 476,072$214.5K2022-05-13
2022-12-15S, sale reported on Form 45,764$18.7K2022-12-16
2022-12-15S, sale reported on Form 46,137$18.8K2023-02-17
2023-06-26S, sale reported on Form 420,000$160.6K2023-06-28
2023-07-05S, sale reported on Form 44,336$34.7K2023-07-07
2023-07-10S, sale reported on Form 410,508$84.2K2023-07-11
2023-07-11S, sale reported on Form 45,156$41.3K2023-07-11
2023-12-15S, sale reported on Form 414,539$124.7K2023-12-19
2024-02-06S, sale reported on Form 413,958$169.2K2024-02-08
2024-02-07S, sale reported on Form 426,042$320.3K2024-02-08
2024-03-06S, sale reported on Form 440,000$648.4K2024-03-08
2024-12-16S, sale reported on Form 424,660$204.2K2024-12-17
2025-09-22S, sale reported on Form 4125,000$1.4M2025-09-24
2025-09-30S, sale reported on Form 434,538$414.8K2025-10-02
2025-10-01S, sale reported on Form 453,001$638.7K2025-10-02
2025-10-06S, sale reported on Form 437,461$461.5K2025-10-08
2025-12-16S, sale reported on Form 433,374$302.4K2025-12-17

4D Molecular Therapeutics, Inc. (FDMT)

Director · 6 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-04-21S, sale reported on Form 45,000$100.2K2023-04-25
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1608936) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms